votucalis (Akari Therapeutics/University of Durham/University of Newcastle)

N/A

Report date: 2025/01/26 17:27:14

Base Information

Drug Namevotucalis (Akari Therapeutics/University of Durham/University of Newcastle)
Drug Alias NameHistamine modulator (Akari Therapeutics, University of Durham)Histamine modulator (Akari Therapeutics/University of Durham/University of Newcastle)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionHistamine modulators
TargetsUpdating
Therapy Area/IndicationsPainPsoriasisPruritus +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeak Bio Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPainPsoriasisPruritus +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A